Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
- PMID: 33761225
- DOI: 10.1056/NEJMc2101282
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Comment in
-
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Reply.N Engl J Med. 2021 Mar 25;384(12):1176-1177. doi: 10.1056/NEJMc2101282. N Engl J Med. 2021. PMID: 33761226 No abstract available.
Comment on
-
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.N Engl J Med. 2020 Dec 24;383(26):2557-2570. doi: 10.1056/NEJMra1307118. N Engl J Med. 2020. PMID: 33369357 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous